Processa Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Processa Pharmaceuticals Stock Summary

Processa Pharmaceuticals competes with Acurx Pharmaceuticals, Fennec Pharmaceuticals, SAB Biotherapeutics, Third Harmonic, and Inhibrx. Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. The company was incorporated in 2011 and is based in Hanover, Maryland. Processa Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.

Processa Pharmaceuticals Key Financial Ratios

Processa Pharmaceuticals Key Balance Sheet Accounts

Processa Pharmaceuticals Key Income Statement Accounts

Processa Pharmaceuticals Key Cash Accounts

Processa Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Processa Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Processa Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Processa Pharmaceuticals competition to find correlations between indicators driving Processa Pharmaceuticals's intrinsic value. More Info.Processa Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Processa Pharmaceuticals' Return On Equity is projected to drop slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Processa Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Processa Pharmaceuticals Systematic Risk

Today, most investors in Processa Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Processa Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Processa Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Processa Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Processa Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Processa Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Processa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Processa Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.